VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 147 filers reported holding VIKING THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $5,864,494 | -25.7% | 110,630 | +14.9% | 0.00% | -50.0% |
Q1 2024 | $7,895,534 | +344.2% | 96,287 | +0.8% | 0.00% | – |
Q4 2023 | $1,777,365 | +69.7% | 95,506 | +1.0% | 0.00% | – |
Q3 2023 | $1,047,222 | -31.9% | 94,600 | -0.2% | 0.00% | – |
Q2 2023 | $1,536,742 | +204.5% | 94,802 | +212.8% | 0.00% | – |
Q1 2023 | $504,644 | +582.0% | 30,309 | +22.6% | 0.00% | – |
Q1 2022 | $74,000 | -35.1% | 24,729 | 0.0% | 0.00% | – |
Q4 2021 | $114,000 | -26.9% | 24,729 | 0.0% | 0.00% | – |
Q3 2021 | $156,000 | +122.9% | 24,729 | +111.3% | 0.00% | – |
Q2 2021 | $70,000 | 0.0% | 11,706 | +4.7% | 0.00% | – |
Q1 2021 | $70,000 | +70.7% | 11,178 | +53.6% | 0.00% | – |
Q4 2020 | $41,000 | -2.4% | 7,279 | 0.0% | 0.00% | – |
Q3 2020 | $42,000 | -41.7% | 7,279 | -26.9% | 0.00% | – |
Q2 2020 | $72,000 | +63.6% | 9,956 | +6.3% | 0.00% | – |
Q1 2020 | $44,000 | -56.9% | 9,362 | -26.2% | 0.00% | – |
Q4 2019 | $102,000 | +25.9% | 12,688 | +8.4% | 0.00% | – |
Q3 2019 | $81,000 | -17.3% | 11,707 | 0.0% | 0.00% | – |
Q2 2019 | $98,000 | -15.5% | 11,707 | 0.0% | 0.00% | – |
Q1 2019 | $116,000 | +41.5% | 11,707 | +9.4% | 0.00% | – |
Q4 2018 | $82,000 | -39.3% | 10,704 | +38.0% | 0.00% | – |
Q3 2018 | $135,000 | +117.7% | 7,759 | +19.5% | 0.00% | – |
Q2 2018 | $62,000 | – | 6,495 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |